Premium
Variation of urinary excretion of aspartylglucosamine and associated clinical findings in aspartylglucosaminuria
Author(s) -
Aula P.,
Raivio K. O.,
Maury P.
Publication year - 1980
Publication title -
journal of inherited metabolic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 102
eISSN - 1573-2665
pISSN - 0141-8955
DOI - 10.1007/bf02312551
Subject(s) - excretion , medicine , urinary system , urine , endocrinology , physiology , gastroenterology
The urinary excretion of aspartylglucosamine (AADG), the main accumulating glycoprotein degradation product in aspartylglucosaminuria (AGU), was studied in 40 patients at various stages of the disease. Only slight variation was found when the amount of AADG excreted by ten AGU patients under 10 years of age was compared with AADG excretion of older patients at a clinically advanced stage of the disease. The 24 h AADG excretion of the younger patients was 354 mg compared with 441 mg in the group often patients over 20 years of age. Clinical symptoms were unrelated to AADG excretion.